$MPLT
MapLight Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
MapLight Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is MPLT down today? It is at $5.94 (-7.48%), and our scanner flagged it 83 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MPLT spikes, and full due diligence on MPLT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MPLT 83 times in the last 30 days. Create a free account to track $MPLT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how MPLT traded in the last session, Friday (last price and move above). Our scanner fired 13 unusual-volume and momentum alerts on MPLT on Friday, peaking at 32.3x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystPriced share offering, from an SEC filing. Read it →Latest filingEFFECTRegistration declared effectiveNov 18, 2026 · 4 days agoAcross every filing on file, supply equal to 331.3% of the tradeable float is in play - 331.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Prospectus update and an active shelf on file: the company can issue new shares
26,362,110 new shares · About $150.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kroeger Christopher A. Officer | Sold (automatic/other) | -74K 0.1% of company | sold 5.8% | 1.20M | $595K at $8.08 | Oct 15, 26 |
Lillie James Woodruff Officer | Sold (automatic/other) | -12K 0.02% of company | sold 5.5% | 199K | $93K at $8.08 | Oct 15, 26 |
Gillis Jonathan Officer | Sold (automatic/other) | -10K 0.02% of company | sold 6.7% | 142K | $82K at $8.08 | Oct 15, 26 |
Hanson Kristopher Officer | Sold (automatic/other) | -9K 0.02% of company | sold 6.6% | 128K | $73K at $8.08 | Oct 15, 26 |
Foff Erin Pennock Officer | Sold (automatic/other) | -15K 0.03% of company | sold 4.9% | 297K | $124K at $8.08 | Oct 15, 26 |
Kreitzer Anatol Officer | Sold (automatic/other) | -12K 0.02% of company | sold 6.8% | 169K | $96K at $7.84 | Oct 15, 26 |
Hanson Kristopher Officer | Sold (automatic/other) | -17K 0.03% of company | sold 11% | 137K | $193K at $11.67 | Sep 16, 26 |
Kroeger Christopher A. Officer | Acquired (grant/award) | +23K 0.04% of company | added 1.9% | 1.27M | n/a | Aug 17, 26 |
Foff Erin Pennock Officer | Acquired (grant/award) | +13K 0.02% of company | added 4.5% | 312K | n/a | Aug 17, 26 |
Gillis Jonathan Officer | Acquired (grant/award) | +8K 0.01% of company | added 5.7% | 152K | n/a | Aug 17, 26 |
Hanson Kristopher Officer | Acquired (grant/award) | +8K 0.01% of company | added 5.3% | 154K | n/a | Aug 17, 26 |
Lillie James Woodruff Officer | Acquired (grant/award) | +8K 0.01% of company | added 3.8% | 210K | n/a | Aug 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how MPLT traded in the last session, Friday (last price and move above). Our scanner fired 13 unusual-volume and momentum alerts on MPLT on Friday, peaking at 32.3x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
MPLT last traded at $5.94, down 7.48% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The MPLT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MPLT 83 times in the last 30 days.
MPLT (MapLight Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $330M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MPLT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MPLT discussion
Sign in to ask a question or join the discussion.